MILFORD, Mass., Aug. 3, 2016 /PRNewswire/ -- SeraCare Life Sciences, a leading partner to clinical laboratories and global in vitro diagnostics manufacturers, announced at the American Association of Clinical Chemistry (AACC) conference today the launch of its newly redesigned website, www.seracare.com. The new website redesign is an extension of the rebranding initiative kicked off at AACC last year as part of the company's ongoing business expansion into the support of genomic diagnostics assay development.
"Our website redesign project has been an important initiative that will improve the way our customers communicate with us and learn about our growing portfolio of innovative QC technologies and reference materials as well as the SeraCare brand. I'm proud to invite visitors to explore our new website and discover how much easier it is to use and how much rich, useful content it now hosts," said Charlie Mamrak, CEO of SeraCare. "We are continuing to invest in keeping SeraCare the leader in our space and this new website is an important milestone in that ongoing effort."
This key investment is part of SeraCare's multi-faceted branding initiative as we expand our focus and expertise towards the adoption of advanced genomic technologies into the clinical laboratory.
Beyond a sleeker, more responsive design, key usability features of the new site include:
- Improved search functionality – The site's search function now provides more accurate results and includes SeraCare's line of KPL™ branded immunoassay reagents and kits.
- Resource library – It is now easier than ever to access SeraCare's vast repository of PIs, COAs, data sheets, SDSs, and product literature.
- Expanded product content – A wider array of product information, technical notes, and white papers to help customers learn about how our tools can assist their development, validation, and quality control of their diagnostic assays.
Future enhancements will add e-commerce and global distributor portals to further build on this new platform.
About SeraCare Life Sciences Inc.
SeraCare enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents. For more information, please visit www.seracare.com and follow SeraCare on Twitter (@SeraCare).